About
Fibroblast Regenerative Therapeutics
Areas of Focus
Categories
Stem Cell & Cellular TherapySouthwestern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
125
By Phase
PHASE1/PHASE2: 1EARLY_PHASE1: 1
By Status
NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07096934Lead Sponsor
Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care
PHASE1/PHASE2Not yet recruiting
120 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2027
NCT05080270Lead Sponsor
Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis
EARLY_PHASE1Completed
5 participants
Started: Sep 21, 2020 · Completed: Jun 8, 2021
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...